These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 9863300)
1. [Treatment of multiple sclerosis--1. New drugs may be effective but there still are frequent relapses]. Svenningsson A; Andersson M; Olsson T Lakartidningen; 1998 Dec; 95(49):5623-7, 5630. PubMed ID: 9863300 [TBL] [Abstract][Full Text] [Related]
5. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis. Schwid SR; Panitch HS Clin Ther; 2007 Sep; 29(9):2031-48. PubMed ID: 18035202 [TBL] [Abstract][Full Text] [Related]
6. Disease-modifying therapy in relapsing--remitting multiple sclerosis: efficacy is paramount. Cristiano E Int J Clin Pract Suppl; 2002 Sep; (131):3-7. PubMed ID: 12564806 [TBL] [Abstract][Full Text] [Related]
7. [Drug therapy in multiple sclerosis]. Le Page E; Edan G Rev Prat; 2006 Jun; 56(12):1336-46. PubMed ID: 16948222 [TBL] [Abstract][Full Text] [Related]
8. Early use of interferon beta patients with multiple sclerosis. Bosley EB; Capildeo R Int J Clin Pract Suppl; 2002 Sep; (131):17-22. PubMed ID: 12564808 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study. Cadavid D; Wolansky LJ; Skurnick J; Lincoln J; Cheriyan J; Szczepanowski K; Kamin SS; Pachner AR; Halper J; Cook SD Neurology; 2009 Jun; 72(23):1976-83. PubMed ID: 19279320 [TBL] [Abstract][Full Text] [Related]
10. Current disease-modifying therapies in multiple sclerosis. Kieseier BC; Hartung HP Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379 [TBL] [Abstract][Full Text] [Related]
13. Disease-modifying drugs for the early treatment of multiple sclerosis. Flachenecker P Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542 [TBL] [Abstract][Full Text] [Related]
14. [Mitoxantrone for the treatment of patients with multiple sclerosis]. Komori M; Kondo T; Tanaka M Brain Nerve; 2009 May; 61(5):575-80. PubMed ID: 19514518 [TBL] [Abstract][Full Text] [Related]
15. Interferon beta and multiple sclerosis: look at the evidence. Patti F; Reggio A Int J Clin Pract Suppl; 2002 Sep; (131):23-32. PubMed ID: 12564809 [TBL] [Abstract][Full Text] [Related]
16. Effect of dose and frequency of interferon beta-1a administration on clinical and magnetic resonance imaging parameters in relapsing-remitting multiple sclerosis. Cocco E; Marchi P; Floris G; Mascia MG; Deriu M; Sirca A; Mamusa E; Lai M; Mura M; Mallarini G; Marrosu MG Funct Neurol; 2006; 21(3):145-9. PubMed ID: 17049133 [TBL] [Abstract][Full Text] [Related]
18. Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study. Schwid SR; Thorpe J; Sharief M; Sandberg-Wollheim M; Rammohan K; Wendt J; Panitch H; Goodin D; Li D; Chang P; Francis G; ; Arch Neurol; 2005 May; 62(5):785-92. PubMed ID: 15883267 [TBL] [Abstract][Full Text] [Related]
19. [Therapy of multiple sclerosis]. Simó M Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis]. Cazzato G; Antonello RM; Zorzon M; Torre P; Zivadinov R; Moretti R; Bragadin LM; De Masi R; Nasuelli D Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]